Stephen Liu: Dr. Christine Lovly about biomarker testing in lung cancer at DC Lung 24

Stephen Liu shared on X:

“Dr. Christine Lovly will help us better understand biomarker testing in lung cancer at DC Lung 24. Don’t miss this important update!

Join us Saturday, October 19th in downtown Washington, DC for this IASLC endorsed, one-day CME meeting!”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.